Suppliers / Zenji Pharmaceuticals (Suzhou)

Zenji Pharmaceuticals (Suzhou)

China Updated 9 July 2026

Zenji Pharmaceuticals (Suzhou) is an API manufacturer based in China. It holds 9 active US drug master files and 4 valid CEPs across a filed portfolio of 7 molecules. Its GMP standing is certified by MFDS (Korea).

9
active US DMFs
4
valid CEPs
4
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026.

Registered plants

Site FDA FEI
Xuguan, Suzhou, China Not on file
Xuguan, Suzhou, China Not on file
Suzhou, China Not on file
China, China 3008822863

What they file, and where

Molecule Regulators Docs
Eribulin US FDA 5
Clopidogrel EDQM 2
Lanthanum Carbonate US FDA 2
Celecoxib EDQM 1
Dapagliflozin US FDA 1
Finerenone US FDA 1
Pentoxyverine Hydrogen Citrate EDQM 1

Also appears on these molecule pages

Eribulin API Finerenone API Lanthanum Carbonate API Celecoxib API Clopidogrel API Dapagliflozin API

Filings and GMP by regulator

Regulator Filings GMP certificates
MFDS (Korea) None 2

Comparing suppliers?

Choose your molecules and target markets. Zenji Pharmaceuticals (Suzhou) comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates